EP1537207A2
Recombinant colstridium neurotoxin fragments
Abstract
This record has no abstract on file.
Term
Term ended
Projected expiry passed 12 September 2023, 3 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
49 members in 11 offices
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 241596 | United States of America | – | |
| 24159602 | United States of America | A | |
| 0303824 | United Kingdom | W |
Members49
| Document | Office | Kind | |
|---|---|---|---|
| GB9617671D0 | United Kingdom | D0 | |
| GB9625996D0 | United Kingdom | D0 | |
| CA2264191A1 | Canada | A1 | |
| WO9807864A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU4389597A | Australia | A | |
| ZA977541B | South Africa | B | |
| EP0939818A1 | European Patent Office (EPO) | A1 | |
| AU723397B2 | Australia | B2 | |
| JP2001502890A | Japan | A | |
| US2002044950A1 | United States of America | A1 | |
| US6461617B1 | United States of America | B1 | |
| US2003166238A1 | United States of America | A1 | |
| CA2498502A1 | Canada | A1 | |
| WO2004024909A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2003267559A1 | Australia | A1 | |
| WO2004024909A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP0939818B1 | European Patent Office (EPO) | B1 | |
| AT294238T | Austria | T | |
| ATE294238T1 | Austria | T1 | |
| DE69733146D1 | Germany | D1 | |
| EP1537207A2This record | European Patent Office (EPO) | A2 | |
| DK0939818T3 | Denmark | T3 | |
| US2005244435A1 | United States of America | A1 | |
| JP2005537809A | Japan | A | |
| DE69733146T2 | Germany | T2 | |
| US2006110410A1 | United States of America | A1 | |
| US7192596B2 | United States of America | B2 | |
| US2007184070A1 | United States of America | A1 | |
| US2007248626A1 | United States of America | A1 | |
| AU2003267559B2 | Australia | B2 | |
| JP4273250B2 | Japan | B2 | |
| US2009148888A1 | United States of America | A1 | |
| US2009246827A1 | United States of America | A1 | |
| US2009274708A1 | United States of America | A1 | |
| US2010022751A1 | United States of America | A1 | |
| US7674470B2 | United States of America | B2 | |
| EP2280066A2 | European Patent Office (EPO) | A2 | |
| US2011028691A1 | United States of America | A1 | |
| US7897158B2 | United States of America | B2 | |
| JP2011045377A | Japan | A | |
| EP2280066A3 | European Patent Office (EPO) | A3 | |
| US8012479B2 | United States of America | B2 | |
| US8012491B2 | United States of America | B2 | |
| US8017134B2 | United States of America | B2 | |
| CA2264191C | Canada | C | |
| US8454976B2 | United States of America | B2 | |
| CA2498502C | Canada | C | |
| JP5570936B2 | Japan | B2 | |
| US9006395B2 | United States of America | B2 |
11 legal events, as 2 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Applications withdrawn, deemed to be withdrawn, or refused after publication in hong kongWithdrawnWD | WD | HK | |
| Application deemed to be withdrawnWithdrawn18D | 18D | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWNSTAA | STAA | EP | |
| Licence recorded0101 SYNTAXIN LIMITED111L | 111L | EP | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | EP | |
| Request for extension of the european patent (deleted)DAX | DAX | EP | |
| Requests to designate patent in hong kongDE | DE | HK | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Request for extension of the european patentAX | AX | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 1537207
- Application
- 37482510
Titles3
- German
- REKOMBINANTE CLOSTRIDIUM NEUROTOXIN FRAGMENTE
- English
- RECOMBINANT COLSTRIDIUM NEUROTOXIN FRAGMENTS
- French
- FRAGMENTS RECOMBINANTS DE TOXINES NEUROTOXINES DE CLOSTRIDES
Classification
- CPC, 21
- A61K39/08
- A61K38/00
- A61K39/00
- A61K2039/505
- A61K2039/53
- A61K2039/627
- C07K14/33
- C07K2319/00
- C07K2319/20
- C07K2319/23
- C07K2319/50
- C07K2319/55
- C07K2319/705
- C07K2319/75
- C12N9/52
- C12N15/62
- Y10S530/825
- A61K47/6415
- A61K47/646
- A61P31/04
- A61P43/00
- IPC, 22
- C12N15 09
- A61K
- A61K38 00
- A61K38 16
- A61K39 00
- A61K39 08
- A61K47 48
- A61K48 00
- A61P31 04
- C07K14 33
- C07K14 65
- C07K19 00
- C12N1 19
- C12N1 21
- C12N5 10
- C12N9 52
- C12N15 31
- C12N15 62
- C12P21 02
- C12P21 04
- C12R1 145
- C12R1 19
Designated states31
- Contracting states, 27
- Austria
- Belgium
- Bulgaria
- Switzerland
- Cyprus
- Czechia
- Germany
- Denmark
- Estonia
- Spain
- Finland
- France
- United Kingdom
- Greece
- Hungary
- Ireland
- Italy
- Liechtenstein
- Luxembourg
- Monaco
- Netherlands (Kingdom of the)
- Portugal
- Romania
- Sweden
and 3 moreShow fewer
- Slovenia
- Slovakia
- Türkiye
- Extension states, 4
- Albania
- Lithuania
- Latvia
- North Macedonia